Zum Hauptinhalt springen

High frequency of gross deletions in 5' LTR/gag and nef genes in patients infected with CRF02_AG of HIV type 1 who survived for over 20 years: an association with Korean red ginseng.

Cho, YK ; Jung, YS ; et al.
In: AIDS research and human retroviruses, Jg. 25 (2009-05-01), Heft 5, S. 535-41
academicJournal

Titel:
High frequency of gross deletions in 5' LTR/gag and nef genes in patients infected with CRF02_AG of HIV type 1 who survived for over 20 years: an association with Korean red ginseng.
Autor/in / Beteiligte Person: Cho, YK ; Jung, YS ; Sung, H ; Sim, MK ; Kim, YK
Zeitschrift: AIDS research and human retroviruses, Jg. 25 (2009-05-01), Heft 5, S. 535-41
Veröffentlichung: Larchmont, NY : Mary Ann Liebert ; <i>Original Publication</i>: [New York] : Mary Ann Liebert, [c1987-, 2009
Medientyp: academicJournal
ISSN: 1931-8405 (electronic)
DOI: 10.1089/aid.2008.0301
Schlagwort:
  • Amino Acid Sequence
  • Asian People
  • Codon, Nonsense
  • Female
  • HIV Infections drug therapy
  • Humans
  • Leukocytes, Mononuclear virology
  • Male
  • Molecular Sequence Data
  • Panax chemistry
  • Plant Extracts therapeutic use
  • Polymerase Chain Reaction
  • Sequence Alignment
  • Sequence Analysis, DNA
  • HIV Infections virology
  • HIV Long Terminal Repeat genetics
  • HIV Long-Term Survivors
  • HIV-1 genetics
  • Sequence Deletion
  • gag Gene Products, Human Immunodeficiency Virus genetics
  • nef Gene Products, Human Immunodeficiency Virus genetics
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [AIDS Res Hum Retroviruses] 2009 May; Vol. 25 (5), pp. 535-41.
  • MeSH Terms: HIV Long-Term Survivors* ; Sequence Deletion* ; HIV Infections / *virology ; HIV Long Terminal Repeat / *genetics ; HIV-1 / *genetics ; gag Gene Products, Human Immunodeficiency Virus / *genetics ; nef Gene Products, Human Immunodeficiency Virus / *genetics ; Amino Acid Sequence ; Asian People ; Codon, Nonsense ; Female ; HIV Infections / drug therapy ; Humans ; Leukocytes, Mononuclear / virology ; Male ; Molecular Sequence Data ; Panax / chemistry ; Plant Extracts / therapeutic use ; Polymerase Chain Reaction ; Sequence Alignment ; Sequence Analysis, DNA
  • Molecular Sequence: GENBANK AF238275; AF462695; AF462698; AF462702; AY121443; AY121444; AY121445; AY899286; AY899357; AY899358; AY899365; AY899366; AY899367; AY899368; AY899369; AY899371; EF370355; EF370356; FJ614884; FJ614885; FJ614886; FJ614887; FJ614888; FJ614889; FJ614890; FJ614891; FJ614892; FJ614893; FJ614894; FJ614895; FJ614896; FJ614897; FJ614898; FJ614899; FJ614900; FJ614901; FJ614902; FJ614903; FJ614904; FJ614905; FJ614906; FJ614907; FJ614908; FJ614909; FJ614910; FJ614911; FJ614912; FJ614913; FJ614914; FJ614915; FJ614916; FJ614917; FJ614918; FJ614919; FJ614920; FJ614921; FJ614922; FJ614923; FJ614924; FJ614925; FJ614926; FJ614927; FJ614928; FJ614929; FJ614930; FJ614931; FJ614932; FJ614933; FJ614934; FJ614935; FJ614936; FJ614937; FJ614938; FJ614939; FJ614940; FJ614941; FJ614942; FJ614943; FJ614944; FJ614945; FJ614946; FJ614947; FJ614948; FJ614949; FJ614950; FJ614951; FJ614952; FJ614953; FJ614954; FJ614955; FJ614956; FJ614957; FJ614958; FJ614959; FJ614960; FJ614961; FJ614962; FJ614963; FJ614964; FJ614965; FJ614966; FJ614967; FJ614968; FJ614969; FJ614970; FJ614971; FJ614972; FJ614973; FJ614974; FJ614975; FJ614976; FJ614977; FJ614978; FJ614979; FJ614980; FJ614981; FJ614982; FJ614983; FJ614984; FJ614985; FJ614986; FJ614987; FJ614988; FJ614989; FJ614990; FJ614991; FJ614992; FJ614993; FJ614994; FJ614995; FJ614996; FJ614997; FJ614998; FJ614999; FJ615000; FJ615001; FJ615002; FJ615003; FJ615004; FJ615005; FJ615006; FJ615007; FJ615008; FJ615009; FJ615010; FJ615011; FJ615012; FJ615013; FJ615014; FJ615015; FJ615016; FJ615017; FJ615018; FJ615019; FJ615020; FJ615021; FJ615022; FJ615023; FJ615024; FJ615025; FJ615026; FJ615027; FJ615028; FJ615029; FJ615030; FJ615031; FJ615032; FJ615033; FJ615034; FJ615035; FJ615036; FJ615037; FJ615038; FJ615039; FJ615040; FJ615041; FJ615042; FJ615043; FJ615044; FJ615045; FJ615046; FJ615047; FJ615048; FJ615049; FJ615050; FJ615051; FJ615052; FJ615053; FJ615054; FJ615055; FJ615056; FJ615057; FJ615058; FJ615059; FJ615060; FJ615061; FJ615062; FJ615063; FJ615064; FJ615065; FJ615066; FJ615067; FJ615068; FJ615069; FJ615070; FJ615071; FJ615072; FJ615073; FJ615074; FJ615075; FJ615077; FJ615078; FJ615079; FJ615080; FJ615081; FJ615082; FJ615083; FJ615084; FJ615085; FJ615086
  • Substance Nomenclature: 0 (Codon, Nonsense) ; 0 (Plant Extracts) ; 0 (gag Gene Products, Human Immunodeficiency Virus) ; 0 (nef Gene Products, Human Immunodeficiency Virus) ; 0 (nef protein, Human immunodeficiency virus 1)
  • Entry Date(s): Date Created: 20090425 Date Completed: 20090615 Latest Revision: 20221207
  • Update Code: 20231215

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -